These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 19712036)

  • 21. Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy.
    van Vonderen MG; Smulders YM; Stehouwer CD; Danner SA; Gundy CM; Vos F; Reiss P; Agtmael MA
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):153-61. PubMed ID: 19131894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.
    Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.
    Mosepele M; Mohammed T; Mupfumi L; Moyo S; Bennett K; Lockman S; Hemphill LC; Triant VA
    Cardiovasc J Afr; 2018 May/Jun 23; 29(3):155-161. PubMed ID: 29771268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis.
    Lorenz MW; Stephan C; Harmjanz A; Staszewski S; Buehler A; Bickel M; von Kegler S; Ruhkamp D; Steinmetz H; Sitzer M
    Atherosclerosis; 2008 Feb; 196(2):720-6. PubMed ID: 17275008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term changes in carotid intima-media thickness among HIV-infected children and young adults.
    Ross Eckard A; O'Riordan MA; Storer N; McComsey GA
    Antivir Ther; 2014; 19(1):61-8. PubMed ID: 23985545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rosuvastatin slows progression of subclinical atherosclerosis in patients with treated HIV infection.
    Longenecker CT; Sattar A; Gilkeson R; McComsey GA
    AIDS; 2016 Sep; 30(14):2195-203. PubMed ID: 27203715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
    Kaplan RC; Landay AL; Hodis HN; Gange SJ; Norris PJ; Young M; Anastos K; Tien PC; Xue X; Lazar J; Parrinello CM; Benning L; Tracy RP
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):359-68. PubMed ID: 22592585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-2 levels are associated with carotid artery intima-media thickness.
    Elkind MS; Rundek T; Sciacca RR; Ramas R; Chen HJ; Boden-Albala B; Rabbani L; Sacco RL
    Atherosclerosis; 2005 May; 180(1):181-7. PubMed ID: 15823291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients].
    Ferraro S; Paolillo S; Gargiulo M; Costanzo P; Maggi P; Chirianni A; Chiariello M; Filardi PP
    G Ital Cardiol (Rome); 2009 Sep; 10(9):596-601. PubMed ID: 19891251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.
    Mercié P; Thiébaut R; Lavignolle V; Pellegrin JL; Yvorra-Vives MC; Morlat P; Ragnaud JM; Dupon M; Malvy D; Bellet H; Lawson-Ayayi S; Roudaut R; Dabis F
    Ann Med; 2002; 34(1):55-63. PubMed ID: 12014436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.
    Currier JS; Kendall MA; Zackin R; Henry WK; Alston-Smith B; Torriani FJ; Schouten J; Mickelberg K; Li Y; Hodis HN;
    AIDS; 2005 Jun; 19(9):927-33. PubMed ID: 15905673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low plasma levels of the soluble receptor for advanced glycation end products in HIV-infected patients with subclinical carotid atherosclerosis receiving combined antiretroviral therapy.
    Jeong SJ; Kim CO; Song YG; Baek JH; Kim SB; Jin SJ; Ku NS; Han SH; Choi JY; Lee HC; Kim JM
    Atherosclerosis; 2011 Dec; 219(2):778-83. PubMed ID: 21872861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus.
    Iacobellis G; Pellicelli AM; Sharma AM; Grisorio B; Barbarini G; Barbaro G
    Am J Cardiol; 2007 May; 99(10):1470-2. PubMed ID: 17493483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients.
    Mercié P; Thiébaut R; Aurillac-Lavignolle V; Pellegrin JL; Yvorra-Vives MC; Cipriano C; Neau D; Morlat P; Ragnaud JM; Dupon M; Bonnet F; Lawson-Ayayi S; Malvy D; Roudaut R; Dabis F;
    HIV Med; 2005 Nov; 6(6):380-7. PubMed ID: 16268819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of inflammatory markers and carotid intima-media thickness with the risk of cardiovascular events in high-risk patients.
    Okazaki S; Furukado S; Abe Y; Tanaka M; Miwa K; Yamagami H; Sakaguchi M; Sakoda S; Kitagawa K
    Cerebrovasc Dis; 2010; 30(2):180-7. PubMed ID: 20588013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy.
    Desvarieux M; Boccara F; Meynard JL; Bastard JP; Mallat Z; Charbit B; Demmer RT; Haddour N; Fellahi S; Tedgui A; Cohen A; Capeau J; Boyd A; Girard PM
    AIDS; 2013 Oct; 27(16):2603-14. PubMed ID: 24100713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both HIV-infection and long-term antiretroviral therapy are associated with increased common carotid intima-media thickness in HIV-infected adolescents and young adults.
    Vigano A; Bedogni G; Cerini C; Meroni L; Giacomet V; Stucchi S; Fabiano V; Coletto S; Catalano M; Minola M; Zuccotti GV
    Curr HIV Res; 2010 Jul; 8(5):411-7. PubMed ID: 20426755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micronutrient concentrations and subclinical atherosclerosis in adults with HIV.
    Falcone EL; Mangili A; Tang AM; Jones CY; Woods MN; Polak JF; Wanke CA
    Am J Clin Nutr; 2010 May; 91(5):1213-9. PubMed ID: 20219956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and structural markers of atherosclerosis in human immunodeficiency virus-infected patients.
    van Wijk JP; de Koning EJ; Cabezas MC; Joven J; op't Roodt J; Rabelink TJ; Hoepelman AM
    J Am Coll Cardiol; 2006 Mar; 47(6):1117-23. PubMed ID: 16545639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.